CAMBRIDGE, Mass., April 22, 2026 — Insilico Medicine (“Insilico”, 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, recently published a comprehensive ...
PandaOmics is a cloud-based software platform that applies artificial intelligence and bioinformatics techniques to multimodal omics and biomedical text data for therapeutic target and biomarker ...
In the past week, two announcements from the drug discovery world have had Insilico Medicine’s generative artificial intelligence (AI) target discovery engine, PandaOmics, front and center. The first ...
"Confluences of Medicine is the first book-length exploration in English of issues of medicine and society in premodern Japan. This multifaceted study weaves a rich tapestry of Buddhist healing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results